Black Diamond Therapeutics Inc (BDTX) financials · rev $70.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Black Diamond Therapeutics Inc (BDTX) rev $70.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $70.0M | N/A |
| Operating Income | $12.5M | -$78.8M |
| Net Income | $22.4M | -$69.7M |
| EPS (Diluted) | $0.39 | -$1.27 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $143.0M | $122.6M |
| Current Assets | $132.4M | $101.2M |
| Cash & Equivalents | $21.0M | $36.4M |
| PP&E | $365.0K | $1.39M |
| Total Liabilities | $30.8M | $39.4M |
| Current Liabilities | $15.7M | $20.6M |
| Shareholders' Equity | $112.2M | $83.3M |
| Retained Earnings | -$464.7M | -$487.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $29.6M | -$62.3M |
| CapEx | N/A | N/A |
| Investing Cash Flow | -$44.9M | $17.0M |
| Financing Cash Flow | -$146.0K | $25.5M |
| Net Change in Cash | -$15.4M | -$19.8M |
| Free Cash Flow | N/A | -$62.3M |
FAQ
What is BDTX P/E and revenue?
Black Diamond Therapeutics Inc (BDTX) rev $70.0M.
What is BDTX revenue?
Black Diamond Therapeutics Inc last cached revenue is $70.0M (FY2025).
Is BDTX profitable?
Black Diamond Therapeutics Inc last cached net income is $22.4M (FY2025).
What are BDTX total assets?
Black Diamond Therapeutics Inc last cached total assets are $143.0M (FY2025).
What is BDTX free cash flow?
No cached cash-flow row for BDTX yet.
Not investment advice. Cached statements, not a live tape.